Bansal Pharma Limited - Company Profile

It is a pharma public limited company based in Thane, Maharashtra, India, established in 1997.
1997 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Bansal Pharma Limited

Bansal Pharma Limited, a active public limited company, was established on 11 September 1997 in Thane, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24200MH1997PLC110599. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Sajankumar Rameshwarlal Bajaj (Director), Anil Champalal Jain (Director), Namrata Sajankumar Bajaj (Director). Past directors included Dhananjay Hatle Sabaji, Ajit Ambalal Shah, Namrata Sajankumar Bajaj. It holds no open charges and ₹2.78 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 602-606,Bhoomi Velocity Infotech Park, Plot No.B-39,39A,39A/1,Rd No.23,Wagle In, D. Estate, Thane, Maharashtra, 400604.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24200MH1997PLC110599

  • Registration Number

    110599

  • Incorporation Date

    11 September 1997

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 28 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 2.78 Cr
  • Revenue Growth **** 127.92%
  • Profit Growth **** -141.06%
  • Ebitda **** -89.34%
  • Net Worth -1.00%
  • Total Assets -4.28%
Company report

Bansal Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bansal Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bansal Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Sajankumar Rameshwarlal Bajaj Director 01 Apr 1998 Current
Anil Champalal Jain Director 31 Jul 1999 Current
Namrata Sajankumar Bajaj Director 01 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Jun 2025 Past
Pramod Abcsdd Director 31 Jan 2008 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Director 28 Aug 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bansal Pharma.

Bansal Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 127.92% increase. The company also saw a substantial fall in profitability, with a 141.06% decrease in profit. The company's net worth dipped by a decrease of 1%.

Bansal Pharma revenue growth over time
Bansal Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 127.92%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -4.28%
*******
*******
*******
*******
Profit or Loss
*******
 -141.06%
*******
*******
*******
*******
Net Worth
*******
 -1.00%
*******
*******
*******
*******
EBITDA
*******
 -89.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bansal Pharma?

In 2023, Bansal Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹27,830,000.00

Charges Breakdown by Lending Institutions
  • Corporation Bank : 2.00 Cr
  • The Saraswat Co-Operative Bank Ltd : 0.78 Cr
Latest Charge Details
Date Lender Amount Status
20 Feb 2004 The Saraswat Co-Operative Bank Ltd ₹7.50 M Satisfied
04 Nov 1999 The Saraswat Co-Operative Bank Ltd ₹0.33 M Satisfied
23 Aug 1999 Corporation Bank ₹1.00 Cr Satisfied
23 Aug 1999 Corporation Bank ₹1.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Bansal Pharma?

Unlock and access historical data on people associated with Bansal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bansal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bansal Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bansal Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Bansal Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Namrata Sajankumar Bajaj was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 10 months 20 days . was documented.

  • Balance Sheet

    Bansal Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Charges

    The activity A charge registered on 23 Aug 1999 via Charge ID 90142508 with Corporation Bank was fully satisfied on 31 Aug 2007. was completed.

  • Charges

    Progress on A charge registered on 23 Aug 1999 via Charge ID 90147332 with Corporation Bank was fully satisfied on 31 Aug 2007. was documented.

  • Charges

    Progress on A charge registered on 20 Feb 2004 via Charge ID 90148579 with The Saraswat Co-Operative Bank Ltd was fully satisfied on 20 Jul 2007. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bansal Pharma Limited?

The CIN of Bansal Pharma Limited is U24200MH1997PLC110599.

Where is Bansal Pharma Limited headquartered?

Bansal Pharma Limited is headquartered at 602-606,Bhoomi Velocity Infotech Park, Plot No.B-39,39A,39A/1,Rd No.23,Wagle In, D. Estate, Thane, Maharashtra, 400604.

When was Bansal Pharma Limited incorporated?

Bansal Pharma Limited was incorporated on 11 September 1997.

Who are the current directors of Bansal Pharma Limited?

The current directors of Bansal Pharma Limited are

What is the primary industry of Bansal Pharma Limited?

The primary industry of Bansal Pharma Limited is Trade.

Is Bansal Pharma Limited a listed company?

Bansal Pharma Limited is unlisted.

What is the capital structure of Bansal Pharma Limited?

The authorized capital of Bansal Pharma Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Bansal Pharma Limited?

The compliance status of Bansal Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available